Artwork

Content provided by Zoë Harcombe. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Zoë Harcombe or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!
icon Daily Deals

Zoë chats with Dr Ben Bikman about the use and effects of GLP-1 Agonists (Semaglutide - Ozempic and Wegovy)

1:09:51
 
Share
 

Manage episode 438278834 series 1109802
Content provided by Zoë Harcombe. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Zoë Harcombe or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

In this episode, Zoë chats with Dr Benjamin Bikman about GLP-1 agonists, a class of drugs used for weight loss and diabetes management. They discuss the role of GLP-1 in metabolism, the effects of GLP-1 agonists on weight loss and insulin sensitivity, and the potential side effects and limitations of these drugs.

Dr Bikman explains how GLP-1 agonists slow down intestinal movement, leading to feelings of nausea and reduced appetite. He also discusses the paradox of these drugs stimulating the growth of new fat cells while promoting weight loss.

Full show notes and video over at https://www.zoeharcombe.com

  continue reading

94 episodes

Artwork
iconShare
 
Manage episode 438278834 series 1109802
Content provided by Zoë Harcombe. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Zoë Harcombe or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

In this episode, Zoë chats with Dr Benjamin Bikman about GLP-1 agonists, a class of drugs used for weight loss and diabetes management. They discuss the role of GLP-1 in metabolism, the effects of GLP-1 agonists on weight loss and insulin sensitivity, and the potential side effects and limitations of these drugs.

Dr Bikman explains how GLP-1 agonists slow down intestinal movement, leading to feelings of nausea and reduced appetite. He also discusses the paradox of these drugs stimulating the growth of new fat cells while promoting weight loss.

Full show notes and video over at https://www.zoeharcombe.com

  continue reading

94 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

icon Daily Deals
icon Daily Deals
icon Daily Deals

Quick Reference Guide

Listen to this show while you explore
Play